Biolife Solutions (BLFS) EBITDA Margin (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly EBITDA Margin of 0.1% for Q1 2026, up 236.0% year-over-year from 0.03% in Q1 2025, and down 98.63% quarter-over-quarter from 7.17% in Q4 2025.
Biolife Solutions (BLFS) EBITDA Margin (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported EBITDA Margin for 17 consecutive years, with 0.1% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 236.0% year-over-year to 0.1%; the TTM figure through Mar 2026 stood at 15.39% (down 1325.0% YoY), while the FY2025 annual figure was 17.26%, down 1126.0% from the prior year.
- EBITDA Margin fell to 0.1% in Q1 2026 per BLFS's latest filing, from 7.17% in the prior quarter.
- Across five years, EBITDA Margin topped out at 7.17% in Q4 2025 and bottomed at 218.96% in Q4 2022.
- Historically, EBITDA Margin has averaged 47.4% across 5 years, with a median of 22.0% in 2022.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 17429 bps — and 2023, when it surged 15254 bps.
- Biolife Solutions' EBITDA Margin stood at 218.96% in 2022, then surged by 43 bps to 125.43% in 2023, then soared by 103 bps to 3.59% in 2024, then soared by 100 bps to 7.17% in 2025, then plunged by 99 bps to 0.1% in 2026.
- Business Quant data shows BLFS's EBITDA Margin at 0.1% in Q1 2026, 7.17% in Q4 2025, and 0.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 7.33% |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 5.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96% |
| Mar 31, 2026 | 0.10% |
| Dec 31, 2025 | 7.17% |
| Sep 30, 2025 | -0.32% |
| Jun 30, 2025 | -65.47% |
| Mar 31, 2025 | -2.26% |
| Dec 31, 2024 | 3.59% |
| Sep 30, 2024 | -1.95% |
| Jun 30, 2024 | -6.62% |
| Mar 31, 2024 | -17.88% |
| Dec 31, 2023 | -125.43% |
| Sep 30, 2023 | -65.65% |
| Jun 30, 2023 | -36.35% |
| Mar 31, 2023 | -36.08% |
| Dec 31, 2022 | -218.96% |
| Sep 30, 2022 | -28.81% |
| Jun 30, 2022 | -188.89% |
| Mar 31, 2022 | -22.00% |
| Dec 31, 2021 | -49.50% |
| Sep 30, 2021 | -33.01% |